Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TRIP | IART |
|---|---|---|
| Price | $8.63 | $13.00 |
| Change today | ▲ 1.29% | ▼ 2.40% |
| Market cap | $1.01B | $1.01B |
| Return, 3 months | -35.3% | -29.3% |
| Return, year to date | -40.7% | +4.7% |
| Return, 1 year | -44.4% | -12.2% |
| P/E (TTM) | 287.7 | -144.4 |
| P/B | 1.5 | 1.0 |
| P/E percentile vs own 5y | 89th | 14th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -7.2% | +0.8% |
| Net profit growth (YoY) | -37.8% | +100.9% |
| Gross margin | 92.1% | 52.5% |
| Operating margin | 4.5% | 4.0% |
| Net margin | 0.3% | -0.4% |
| Return on equity | 0.8% | -0.7% |
| Analyst target vs. price | +54.7% | +30.8% |
| Analyst buy share | 36% | 0% |
| RSI (14) | 42 | 31 |
| 30-day volatility | 38.0% | 78.1% |
| Max drawdown, 1 year | -53.1% | -44.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
